RxDoctor Payments Data

Michael Foster, DO

Otology & Neurotology · Holland, MINPI 1699067751

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 58 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 18 manufacturers reported payments, led by Stryker at 36.0% of the total.

$3,114in general payments, 2019–2025

Across 58 payments — averaging $53.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$1K
  • Medtronic$502
  • Intersect ENT, Inc.$393
  • Advanced Bionics, LLC$270
  • Acclarent, Inc$211
  • Integra Lifesciences Corporation$196
  • plus $420 from 12 others

What the payments were for

  • Food & beverage$3,114100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,114 in reported general payments places this provider in the 55th percentile of 23 otology & neurotology providers in Michigan.

See all otology & neurotology providers in Michigan

Medicare billing

Part B allowed, 2024
$51,616
Medicare patients
188
Services billed
582

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
XareltoRivaroxaban12$6,021
Ipratropium Bromide76$3,250
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth18$2,135
Famotidine60$1,056
Ofloxacin56$997
Azelastine Hcl33$480
Omeprazole18$449
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip24$255
Mupirocin38$221
Oxycodone Hcl52$91
Prednisone39$58
Fluconazole12$56
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim13$53
Ondansetron Hcl14$47
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen14$38

Paid to pharmacies, not to this prescriber.

Other otology & neurotology in Holland

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →